Snapshot A 38-year-old G3P2 woman visits her obstetrician for a routine prenatal visit. She is at 28 weeks of gestation and has had an uneventful, normal pregnancy so far. Her obstetrician presents various options for postpartum contraception, including permanent sterilization, progestin implants, intrauterine devices (IUD), and short-acting hormonal contraception. The woman elects to have a copper intrauterine device implanted after her delivery. Years later, a pelvic radiograph is obtained for the woman and the position of her IUD can be observed, as seen in the image. Introduction Overview postpartum contraception is a method to prevent unintentional pregnancies and avoid short interpregnancy intervals after giving birth important as pregnancies in the postpartum period within 12-18 months of a live birth have significant risks for adverse maternal, perinatal, and infant outcomes login to view 1 more bullet Methods Permanent sterlization of the female or male partner efficacy rates > 99% login to view 5 more bullets progestin-only implants i.e., etonogestrel (Nexplanon) and levonorgestrel (Jadelle) implants login to view 1 more bullet intrauterine devices (IUDs) i.e., copper IUD and levonorgestrel-releasing IUD login to view 4 more bullets short-acting hormonal contraception i.e., progestin injections, oral pills, patch, and vaginal ring progestin-only methods can be started at any time in the postpartum period combined estrogen-progestin hormonal contraception should NOT be initiated earlier than 21 days postpartum login to view 1 more bullet Complications Venous thromboembolism incidence 3-7x higher in women who use combined hormonal contraceptives in the initial postpartum period risk factors use of combined estrogen-progestin hormonal contraception in the initial 3-6 weeks postpartum period